[ET Net News Agency, 16 November 2018] Daiwa Research lowered its target price for PICC
Group (01339) to HK$4.2 from HK$5 and maintained its "buy" rating.
The research house cited PICC management saying that it will promote its critical
illness products, such as "Wu You Ren Sheng", and other long-term regular premium
products, along with some savings products. Pricing interest rates for these products have
been capped at 3.5%. Management expects negative growth in savings products during the
jumpstart period.
For 2019, PICC Life plans to focus more on products with high VNB and regular premium,
and actively cut down the proportion of short-term and single-premium products. PICC Life
targets positive YoY growth in both VNB and FYP for 2019.
Daiwa cut its 2018-20 net profit forecasts by 3-16%, mainly due to earnings cuts at PICC
P&C (02328). (KL)